As a result, Panax ginseng treatment significantly diminished NAFLD-induced systemic ALT, AST, TG, TC, LDL, and fasting blood glucose levels while elevating HDL levels in animals. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.